Background Thyroid eye disease is a disorder
Thyroid eye disease is an autoimmune disorder in which there is lymphocytic infiltration of the extraocular muscles, and an accumulation of glycosaminoglycans in the orbital fat which leads to an increase in the volume of the orbital tissue. Depending on the severity, this results in orbital congestion, proptosis, lid retraction, restrictive myopathy with diplopia and in the worst cases corneal exposure and compressive optic neuropathy. 1 The clinical course is progressive over months to years. Some clinical signs persist after resolution due to cicatricial changes.
Treatment of thyroid eye disease consists of lubrication for corneal exposure, systemic immunosuppression, radiation therapy and surgery. Systemic corticosteroids are useful in the acute phase of the disease. However treatment may need to be continued for a long time, and results in side effects. External beam radiation may be employed to limit the amount of proptosis and optic nerve compression. Orbital decompressive surgery is indicated if the above treatment modalities fail to control compressive optic neuropathy or severe corneal exposure. It is also used to minimise cosmetic deformity due to proptosis. Surgical decompression involves removing one to four of the bony orbital walls and incising the orbital peri ostium allowing the swollen orbital contents to prolapse into the adjacent spaces. This can be achieved either externally or using an endoscopic approach.
This paper reports on the results and complications of endoscopic decompression in such patients with thyroid orbitopathy.
Patients and methods
Seven patients underwent bilateral endoscopic orbital decompressions. There were 3 men and 4 women with a mean age of 37 (range 19 to 62) years. Indications for surgical decompression are listed in Table 1 . Prior therapy included systemic immunosuppression and radiotherapy. Some patients went on to have either squint or oculoplastic surgery.
Preoperative assessment included a complete ophthalmological and orthoptic assessment including Hertel exophthalmometry and Hess charts to assess the degree of exophthalmos and oculomotility. Otolaryngologic assessment included nasal endoscopy to identify any sinus or septal pathology. Imaging included either computerised tomography (CT) or magnetic resonance imaging (MRl). All operations were performed under general anaesthesia. All patients were followed at least 12 months post operatively.
The aim is to remove the entire medial wall and part of the floor of the orbit so that the orbital contents can prolapse into the ethmoidal and maxillary cavities. A pre-operative nasal examination and coronal CT scan of the sinuses are performed to provide accurate details of the variable ethmoidal anatomy and to identify any co existing sinonasal pathology.
The operation is performed under general anaesthesia with the patient in a supine position. The nasal cavity is instilled with a mixture of 2 ml of 10% cocaine and 1 ml mixture of 1:1000 adrenaline solution followed by infiltration of the lateral nasal wall with a 1 ml mixture of 1:80 000 adrenaline and 2% xylocaine.
A standard endoscopic sphenoethmoidectomy is performed and the medial wall of the orbit is carefully skeletonised and fully exposed as far back as the orbital apex. A generous middle meatal antrostomy is fashioned for access to the orbital floor. The thin bone of the medial orbital wall (lamina papyracea) is removed after careful separation from the periorbita with a Freer elevator.
Bony decompression of the orbital floor extends up to the infraorbital nerve canal to avoid damaging the nerve. Excessive decompression of the orbital floor may also lead to post-operative diplopia or aggravate a pre existing diplopia 1 and increases the risk of recurrent maxillary sinusitis ? In practice, surgical access to the The patient is maintained on antibiotics (Augmentin) for 5 days post-operatively and advised not to blow the nose for a week.
Results
There were no intra-operative or post-operative complications. All the patients except one were discharged within 24 hours. The other patient remained an extra day due to the effect of the general anaesthetic. The follow-up period was at least 12 months. Proptosis was reduced an average of 3.79 mm (range 2-7). There was no statistical correlation between the reduction in proptosis with age, sex, side of operation, surgical indication, preoperative proptosis, and duration of the disease process.
Four patients whose surgery was performed for cosmesis were pleased with their post-operative appearance. Two of these patients have had oculoplastic surgery. The patient whose surgery was performed for subluxation of the globe and acute proptosis experienced no further episodes. The patient with compressive optic neuropathy had a post-operative improvement in visual acuity with no further loss in optic nerve function. In the seventh patient the exposure keratopathy improved post operatively. Two patients had preoperative diplopia, which in one patient increased post-operatively from 18 to 30 prism dioptres base out for near and from 20 to 35 prism dioptres base out for distance. There was minimal post operative change in the second patient. Both patients went on to have squint surgery. The remaining five patients had no change in oculomotility, with two patients experienced a 'freeing of their eyes'. These results are summarised in Table 3 .
Discussion
Thyroid eye disease can be divided into two broad stages. Initially there is an acute active inflammatory and congestive phase lasting 6-18 months. This stage is mediated by lymphocytes and fibroblasts and is partially responsive to immunosuppression and radiotherapy. 1 Corticosteroids are the most commonly used immunosuppressive agents, being particularly useful in patients with acute inflammatory orbital disease and optic neuropathy. Although these are improved with steroids, the problem recurs on cessation of therapy. There are many contra indications to, and complications of, steroid therapy. Corticosteroids have little effect on exophthalmos and not all patients respond to treatment. Immunosuppression can also be achieved with cyclosporin, methotrexate and azathioprine. All these agents can be associated with serious systemic complications and are not as effective as corticosteroids in controlling the inflammation. 1 The role of radiotherapy in the treatment of thyroid eye disease is still questioned. A dose of 20 Gy is recommended by most authors. Radiotherapy is associated with a significant improvement in subjective and objective signs of orbital congestion, in relief of compressive optic neuropathy, and fewer complications than high dose corticosteroids. 3 Table 3 . A summary of post-operative changes The acute phase is followed by a chronic stable phase with hypertrophy and fibrosis of the extraocular muscles, lacrimal gland and orbital fat. These changes are usually permanent and unresponsive to either steroids or radiotherapy. Surgical treatment is required to treat this stage. 4 Occasionally, a few patients require orbital decompression in the acute phase when visual acuity is threatened.
Unlike steroids and radiotherapy which try to control the local inflammatory process albeit temporarily, surgery permanently enlarges the orbital volume to With improved technology in fibreoptic instrumentation orbital structures can be safely and effectively operated on intranasally. Endoscopic dacryocystorhinostomy and orbital decompressions have been shown to be both effective and associated with a low morbidity. [6] [7] [8] Endoscopic orbital surgery allows clear visualisation of orbital structures with no need for a skin incision.
Some authors have suggested that severe septal deviation is a contraindication to endoscopic orbital surgery. We do not feel that this is the case as obstructing intranasal pathology is simply treated at the same time.
Only 1 of our patients required a minor septoplasty at the time of surgery.
In our series of 14 orbits, we report a reduction in
proptosis by an average of 3.79 mm, range 2 to 7 mm. This is in keeping with other reported series of endoscopic decompression. Our results show that endoscopic orbital decompression achieves a similar reduction in proptosis compared with a traditional external approach, and is associated with a lower incidence of post-operative complications. The endoscopic approach avoids post operative infraorbital nerve anaesthesia as identification of the nerve is possible and it is not traumatised. As visualisation especially in the region of the ethmoid roof and orbital apex is better endoscopically compared with an external approach decompression of the optic nerve is achieved more safely by this approach. Furthermore, an external decompression may be followed by post operative hypoglobus,ll a complication not seen in our patients.
A worsening of extraocular muscle balance may follow orbital decompression with reported incidences being as high as 69% following successful surgeryY McCord has highlighted the relatively low incidence of post-operative diplopia associated with a translid versus the trans antral approachY In his series a 40% worsening of diplopia was associated with transantral compared with 5.6% incidence following the trans lid approach. In our series only 1 patient has a worsening of diplopia after surgery. Furthermore, none of the patients developed a significant A pattern, a complication thought to be caused by disturbance to the origin of the inferior oblique muscle.
Endoscopic decompression can be performed under local anaesthesia. In addition to a more rapid post operative recovery, the use of local anaesthesia enables intraoperative monitoring of the patient's vision, reducing the likelihood of accidental optic nerve damage.
In conclusion, endoscopic orbital decompression is a safe and effective treatment for dysthyroid eye disease associated with lower post-operative complications compared with conventional external orbital surgery. The decision to enlarge the orbital space should be considered carefully with close co-operation between ophthalmologists and ENT surgeons.
